Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > BioHub
View:
Post by BioTeck on May 26, 2022 2:20pm

BioHub

Anyone have any more info on DRI's BioHub? It appears they were able to get someone off insulin way back in 2015. From what I see, they could have a device that does what the Cell Pouch does. 



https://www.prnewswire.com/news-releases/diabetes-research-institutes-first-patient-in-biohub-trial-no-longer-requires-insulin-therapy-300140102.html
Comment by Stockfshr on May 26, 2022 3:38pm
See link below for a November 2021 article that indicates that DRIs "mini-pancreas" phase I/II trial is ongoing and that DRI announced its first successful results in 2016. Does make one wonder what has been going on since 2016, though. DRI website mentions this program but provides no updates either as I'm sure you know. The rest of the article provides a good list of current ...more  
Comment by BioTeck on May 26, 2022 3:56pm
Yeah, I've seen that. Weird part is that Camillo Ricordi and Tomei were the ones who came up with the Conformal Coating. If they are working on something similar on their own, why would they license it out to Sernova? Only thing I can think of is that they don't have cells but this is from 2014 so I'm sure they could have teamed up with Semma, Evotec, etc. etc.  The other ...more  
Comment by Stockfshr on May 26, 2022 5:49pm
Conformal coating - Sernova "entered into an exclusive, worldwide licence with the University of Miami at Coral Gables, Florida, for the commercial rights to novel conformal coating immune protection technologies. The technologies were developed by Dr. Alice Tomei, Dr. Jeffrey Hubbell, and Aaron Stock (Graduate Student)." This license is with the University of Miami (which DRI and BioHub ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities